Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) Net Margin (2016 - 2026)

Cumberland Pharmaceuticals' Net Margin history spans 15 years, with the latest figure at 7.89% for Q4 2025.

  • On a quarterly basis, Net Margin rose 741.0% to 7.89% in Q4 2025 year-over-year; TTM through Dec 2025 was 5.65%, a 1056.0% increase, with the full-year FY2025 number at 5.65%, up 1056.0% from a year prior.
  • Net Margin hit 7.89% in Q4 2025 for Cumberland Pharmaceuticals, up from 23.5% in the prior quarter.
  • Over the last five years, Net Margin for CPIX hit a ceiling of 10.66% in Q1 2025 and a floor of 67.38% in Q4 2023.
  • Historically, Net Margin has averaged 8.51% across 4 years, with a median of 7.34% in 2025.
  • The widest YoY moves for Net Margin: up 5208bps in 2024, down -2426bps in 2024.
  • Tracing CPIX's Net Margin over 4 years: stood at 6.05% in 2021, then crashed by -1214bps to 67.38% in 2023, then soared by 77bps to 15.3% in 2024, then surged by 48bps to 7.89% in 2025.
  • Business Quant data shows Net Margin for CPIX at 7.89% in Q4 2025, 23.5% in Q3 2025, and 6.78% in Q2 2025.